Are you Dr. Czerniak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Bogdan Czerniak, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and New York. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1990 - 1992
Pomeranian Academy of Medicine in SzczecinClass of 1973
Certifications & Licensure
TX State Medical License 1993 - 2025
NY State Medical License 1991 - 1994- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.Georges C Tabet, Lan Zheng, Hossein Hosseini, John Ward, Louis Pisters
Human Pathology. 2024-11-01 - Bladder cancer variants - one disease with many faces.Bogdan Czerniak
Nature Reviews. Urology. 2024-09-01 - METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics.Jiahui Jiang, Yunhe Liu, Jiangjiang Qin, Jianfeng Chen, Jingjing Wu
Nature Communications. 2024-08-25
Press Mentions
MD Anderson Receives over $31 Million in CPRIT FundingFebruary 16th, 2022
The 58th Annual Symposium of the Houston Society of Clinical PathologistsNovember 14th, 2018
Molecular Profile of Invasive Bladder Cancer Resembles That of Breast CancerFebruary 20th, 2014- Join now to see all
Grant Support
- Multidisciplinary Subspecialty Pathology Research Fellowship ProgramNational Cancer Institute2011
- Aurora Kinase A As A Biomarker For The Detection Of Bladder CancerNational Cancer Institute2010–2011
- Specimen CoreNational Cancer Institute2008–2010
- Forerunner Genes: A Novel Class Of Early Detection Markers For Bladder CancerNational Cancer Institute2008–2010
- Early Detection Of Urinary Bladder CancerNational Cancer Institute1999–2009
- Paradigm Of Multistep Urinary Bladder CarcinogenesisNational Cancer Institute2002–2006
- Core--Tissue Resource And PathologyNational Cancer Institute2002
- Early Detection And Chemoprevention Of Bladder CancerNational Cancer Institute2001–2002
- Paradigm Of Multistep Urinary Bladder CarcinogenesisNational Cancer Institute1995–1999
